Modulation of natural killer cell functions by interactions between 2B4 and CD48 in cis and in trans

Open Biology

Volumn 6, Issue 5, 2016, Pages

  Claus, Maren ^a   Wingert, Sabine ^a   Watzl, Carsten ^a  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

2B4; CD48; Cytotoxicity; Natural killer cells; Surface receptors

Indexed keywords

CD244 PROTEIN, HUMAN; CD48 ANTIGEN; CD48 PROTEIN, HUMAN; PROTEIN BINDING; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE;

BINDING SITE; CHEMISTRY; COCULTURE; CYTOLOGY; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; JURKAT CELL LINE; METABOLISM; NATURAL KILLER CELL; PHOSPHORYLATION;

BINDING SITES; CD48 ANTIGEN; COCULTURE TECHNIQUES; HEK293 CELLS; HUMANS; JURKAT CELLS; KILLER CELLS, NATURAL; PHOSPHORYLATION; PROTEIN BINDING; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE FAMILY;

EID: 84978299781     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.160010     Document Type: Article

References (50)

1. Moretta L, Moretta A. 2004 Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23, 255-259. (doi:10.1038/sj. emboj.7600019)
2. Lanier LL. 2008 Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9, 495-502. (doi:10.1038/ni1581)
3. Veillette A. 2006 Immune regulation by SLAM family receptors and SAP-related adaptors. Nat. Rev. Immunol. 6, 56-66. (doi:10.1038/nri1761)
4. Claus M, Meinke S, Bhat R, Watzl C. 2008 Regulation of NK cell activity by 2B4, NTB-A and CRACC. Front. Biosci. 13, 956-965. (doi:10.2741/2735)
5. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. 1998 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188, 2083-2090. (doi:10.1084/jem.188.11.2083)
6. Latchman Y, McKay PF, Reiser H. 1998 Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol. 161, 5809-5812.
7. Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. 1999 Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 162, 6981- 6985.
8. Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C. 2005 Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105, 4722-4729. (doi:10.1182/blood-2004-09-3796)
9. Bryceson YT, March ME, Ljunggren H-G, Long EO. 2006 Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107, 159-166. (doi:10. 1182/blood-2005-04-1351)
10. Hoffmann SC, Cohnen A, Ludwig T, Watzl C. 2011 2B4 engagement mediates rapid LFA-1 and actindependent NK cell adhesion to tumor cells as measured by single cell force spectroscopy. J. Immunol. 186, 2757-2764. (doi:10.4049/ jimmunol.1002867)
11. Sandusky MM, Messmer B, Watzl C. 2006 Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation. Eur. J. Immunol. 36, 3268-3276. (doi:10.1002/eji. 200636146)
12. Mathew SO, Vaidya SV, Kim JR, Mathew PA. 2007 Human natural killer cell receptor 2B4 (CD244) down-regulates its own expression by reduced promoter activity at an Ets element. Biochem. Biophys. Res. Commun. 355, 483- 487. (doi:10. 1016/j.bbrc.2007.01.176)
13. Velikovsky CA, Deng L, Chlewicki LK, Fernández MM, Kumar V, Mariuzza RA. 2007 Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family. Immunity 27, 572-584. (doi:10.1016/j.immuni.2007.08.019)
14. Ames JB, Vyas V, Lusin JD, Mariuzza RA. 2005 NMR structure of the natural killer cell receptor 2B4 (CD244): implications for ligand recognition. Biochemistry 44, 6416- 6423. (doi:10.1021/ bi050139s)
15. Davis SJ, van der Merwe PA. 1996 The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 17, 177-187. (doi:10. 1016/0167-5699(96)80617-7)
16. Held W, Mariuzza RA. 2008 Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat. Rev. Immunol. 8, 269-278. (doi:10.1038/nri2278)
17. Ito D, Iizuka Y-M, Katepalli MP, Iizuka K. 2009 Essential role of the Ly49A stalk region for immunological synapse formation and signaling. Proc. Natl Acad. Sci. USA 106, 11 264-11 269. (doi:10.1073/pnas.0900664106)
18. Back J, Chalifour A, Scarpellino L, Held W. 2007 Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact. Proc. Natl Acad. Sci. USA 104, 3978-3983. (doi:10.1073/pnas.0607418104)
19. Jonsson AH, Yang L, Kim S, Taffner SM, Yokoyama WM. 2010 Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J. Immunol. 184, 3424-3432. (doi:10.4049/jimmunol.0904057)
20. Chalifour A et al. 2009 A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 30, 337-347. (doi:10.1016/j.immuni.2008.12.019)
21. Uehara T et al. 2001 Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. J. Clin. Invest. 108, 1041- 1050. (doi:10. 1172/JCI12195)
22. Ho LH, Uehara T, Chen CC, Kubagawa H, Cooper MD. 1999 Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. Proc. Natl Acad. Sci. USA 96, 15 086-15 090. (doi:10.1073/ pnas.96.26.15086)
23. Bastisch I, Tiede A, Deckert M, Ziolek A, Schmidt RE, Schubert J. 2000 Glycosylphosphatidylinositol (GPI)-deficient Jurkat T cells as a model to study functions of GPI-anchored proteins. Clin. Exp. Immunol. 122, 49-54. (doi:10.1046/j.1365-2249. 2000.01350.x)
24. Mathew SO, Kumaresan PR, Lee JK, Huynh VT, Mathew PA. 2005 Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells. J. Immunol. 175, 1005- 1013. (doi:10.4049/jimmunol.175. 2.1005)
25. Freeman MM, Seaman MS, Rits-Volloch S, Hong X, Kao CY, Ho DD, Chen B. 2010 Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody. Structure 18, 1632-1641. (doi:10.1016/j.str.2010.09.017)
26. Watzl C, Stebbins CC, Long EO. 2000 NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165, 3545-3548. (doi:10. 4049/jimmunol.165.7.3545)
27. Bottino C, Augugliaro R, Castriconi R, Nanni M, Biassoni R, Moretta L, Moretta A. 2000 Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells. Eur. J. Immunol. 30, 3718-3722. (doi:10.1002/1521-4141(200012) 30:12<3718::AID-IMMU3718>3.0.CO;2-I)
28. Watzl C, Long EO. 2003 Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med. 197, 77-85. (doi:10.1084/jem.20020427)
29. Masuda A, Nakamura A, Maeda T, Sakamoto Y, Takai T. 2007 Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J. Exp. Med. 204, 907- 920. (doi:10. 1084/jem.20060631)
30. Meijers R, Puettmann-Holgado R, Skiniotis G, Liu JH, Walz T, Wang JH, Schmucker D. 2007 Structural basis of Dscam isoform specificity. Nature 449, 487-491. (doi:10.1038/nature06147)
31. Kelm S, Gerlach J, Brossmer R, Danzer CP, Nitschke L. 2002 The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J. Exp. Med. 195, 1207- 1213. (doi:10.1084/jem.20011783)
32. Jin L, McLean PA, Neel BG, Wortis HH. 2002 Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J. Exp. Med. 195, 1199- 1205. (doi:10.1084/jem. 20011796)
33. Collins BE, Blixt O, DeSieno AR, Bovin N, Marth JD, Paulson JC. 2004 Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc. Natl Acad. Sci. USA 101, 6104-6109. (doi:10.1073/pnas. 0400851101)
34. Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT. 1995 A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269, 242- 244. (doi:10. 1126/science.7618087)
35. Parolini S et al. 2000 X-linked lymphoproliferative disease. 2b4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192, 337-346. (doi:10.1084/jem.192.3.337)
36. Sinha SK, Gao N, Guo Y, Yuan D. 2010 Mechanism of Induction of NK activation by 2B4 (CD244) via its cognate ligand. J. Immunol. 185, 5205-5210. (doi:10.4049/jimmunol.1002518)
37. Doucey M-A, Scarpellino L, Zimmer J, Guillaume P, Luescher IF, Bron C, Held W. 2004 Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat. Immunol. 5, 328- 336. (doi:10. 1038/ni1043)
38. Brusilovsky M, Radinsky O, Cohen L, Yossef R, Shemesh A, Braiman A, Mandelboim O, Campbell KS, Porgador A. 2015 Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in cis: a lesson from NKp44. Eur. J. Immunol. 45, 1180-1191. (doi:10.1002/eji. 201445177)
39. Avril T, North SJ, Haslam SM, Willison HJ, Crocker PR. 2006 Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression. J. Leukoc. Biol. 80, 787-796. (doi:10. 1189/jlb.1005559)
40. Cheung TC et al. 2009 T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment. J. Immunol. 183, 7286-7296. (doi:10.4049/ jimmunol.0902490)
41. Bessoles S, Angelov GS, Back J, Leclercq G, Vivier E, Held W. 2013 Education of murine NK cells requires both cis and trans recognition of MHC class I molecules. J. Immunol. 191, 5044-5051. (doi:10. 4049/jimmunol.1301971)
42. Held W, Mariuzza RA. 2011 Cis- trans interactions of cell surface receptors: biological roles and structural basis. Cell Mol. Life Sci. 68, 3469-3478. (doi:10.1007/s00018-011-0798-z)
43. Fauriat C, Ivarsson MA, Ljunggren H-G, Malmberg K-J, Michaëlsson J. 2010 Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115, 1166-1174. (doi:10.1182/blood-2009-09-245746)
44. Vitale C, Chiossone L, Morreale G, Lanino E, Cottalasso F, Moretti S, Dini G, Moretta L, Mingari MC. 2004 Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation. Eur. J. Immunol. 34, 455-460. (doi:10.1002/eji. 200324668)
45. Sivori S, Falco M, Marcenaro E, Parolini S, Biassoni R, Bottino C, Moretta L, Moretta A. 2002 Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl Acad. Sci. USA 99, 4526-4531. (doi:10.1073/pnas. 072065999)
46. Cosentini E et al. 2012 Killer immunoglobulin-like receptors (KIR) and their HLA-ligands in Italian paroxysmal nocturnal haemoglobinuria (PNH) patients. Tissue Antigens 80, 322-327. (doi:10. 1111/j.1399-0039.2012.01932.x)
47. El-Sherbiny YM, Kelly RJ, Hill A, Doody GM, Hillmen P, Cook GP. 2013 Altered natural killer cell subset homeostasis and defective chemotactic responses in paroxysmal nocturnal hemoglobinuria. Blood 122, 1887-1890. (doi:10.1182/blood-2013-06-507574)
48. El-Sherbiny YM, Doody GM, Kelly RJ, Hill A, Hillmen P, Cook GP. 2015 Natural killer (NK) cell function in paroxysmal nocturnal hemoglobinuria: a deficiency of NK cells, but not an NK cell deficiency. Blood 125, 1351- 1352. (doi:10.1182/blood-2014-07-591255)
49. Watzl C. 2006 Production and use of trimeric isoleucine zipper fusion proteins to study surface receptor ligand interactions. In Current protocols in protein science (eds JE Coligan, BM Dunn, DW Speicher, PT Wingfield). Ch. 19, unit 19.11. New York, NY: John Wiley & Sons Inc.
50. Stark S, Flaig R-M, Sandusky M, Watzl C. 2005 The use of trimeric isoleucine-zipper fusion proteins to study surface-receptor- ligand interactions in natural killer cells. J. Immunol. Methods 296, 149-158. (doi:10.1016/j.jim.2004.11.010)